Trial Profile
Desensitization of renal transplant candidates.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 24 Jul 2012 Trial phase changed from IV to I as reported by ClinicalTrials.gov.
- 08 Mar 2012 Actual patient number is 9 according to ClinicalTrials.gov.
- 21 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.